Inactive Instrument
Lipidor AB Stock Nasdaq Stockholm
Stocks
LIPI
SE0012558617
Pharmaceuticals
OTC Markets Traded| 1 day | -6.52% |
| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 2017-12-31 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 2009-12-31 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 2022-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 2016-12-31 |
| Chairman | 46 | 2019-12-31 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 2019-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.52% | -24.56% | - | - | 92.63K | |
| +0.35% | -4.87% | +49.87% | +157.34% | 1,031B | |
| -2.69% | -6.22% | +59.19% | +54.51% | 595B | |
| +0.44% | -3.41% | +30.97% | +79.48% | 431B | |
| +0.98% | -1.40% | +29.49% | +21.76% | 326B | |
| -0.34% | -3.10% | +27.00% | +43.60% | 277B | |
| +1.63% | -11.76% | +19.72% | +21.72% | 263B | |
| +3.39% | +2.29% | -23.68% | -37.83% | 224B | |
| +0.86% | -2.63% | +22.50% | +57.55% | 193B | |
| +1.28% | -3.03% | +20.76% | +70.62% | 164B | |
| Average | -0.06% | -3.79% | +26.20% | +52.08% | 389.37B | |
| Weighted average by Cap. | +0.21% | -4.31% | +35.59% | +76.50% |
Employees
4
Sector
Pharmaceuticals
Choose MarketScreener 
